ArticleInternational urogynecology journal2026
Trends of Genitourinary Fistula in Kigali, Rwanda, over a 10-year Period.
Article in International urogynecology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Forceps-Assisted Delivery Could Reduce the Iatrogenic Fistula Crisis: A Clinical Commentary.International urogynecology journal · 2026Article
- Commentary on Characteristics Associated with Failure of Obstetrics-Related Vesicovaginal Fistula Surgery.International urogynecology journal · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Genitourinary (GU) fistula most commonly occurs following ischemic damage during protracted labor or iatrogenic injury at time of surgery. Many developing nations report high rates of ischemic fistula, in part due to limited healthcare access. We aimed to assess the etiology and trends of genitourinary fistula in Rwanda over a 10-year period. Retrospective chart review of women presenting for management of fistula in Kigali, Rwanda, between 2013 and 2024. Iatrogenic etiology was defined as those temporally following cesarean section or hysterectomy and included vesico-uterine, vesico-cervical, uretero-vaginal, vesico-vaginal at vaginal cuff, or high vesico-vaginal fistula. All other GU fistula were assigned as ischemic. There were 909 women diagnosed with GU fistula with 416 (46%) characterized as iatrogenic and 493 (54%) as ischemic fistula. Iatrogenic fistula had significantly higher proportions of abdominal routes for repair (40% vs 5%) and abdominal hysterectomies performed (26% vs 5%) compared to ischemic fistulas (p < 0.001). Ischemic fistula were more likely to be recommended for urinary diversion (29% vs. 4%, p < 0.001). There was a significant increase in iatrogenic fistula over time with a 2.1% increase per year (p < 0.001) (Fig. 1). There were 279 women with recurrent GU fistula with a significantly higher proportion of ischemic fistula with recurrence (p < 0.001). There was a significant increase in iatrogenic fistula over a 10-year period in Rwanda resulting from obstetrical and gynecological surgeries. Iatrogenic fistula were more likely to require a more invasive surgical approach while ischemic fistula were more likely to either be recommended for urinary diversion or present with recurrence following repair.
Indexed as
Identifiers
41214283What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.